Novartis divests anti-infectives brands to Samara Capital Industry-The Economic Times — October 5, 2017 comments off The portfolio of brands acquired focus on anti-infectives largely catering to the women’s health and gynaecology segment, the spokesperson added.
The portfolio of brands acquired focus on anti-infectives largely catering to the women’s health and gynaecology segment, the spokesperson added.